Literature DB >> 28133134

[Two Cases of Primary Hepatic Mucosa-Associated Lymphoid Tissue(MALT) Lymphoma].

Yasuhiro Fujiwara1, Kazuhiko Sakamoto, Yoshihiro Tokuhisa, Yukio Tokumitsu, Masao Nakajima, Satoru Matsukuma, Hiroto Matsui, Yoshitaro Shindo, Shinsuke Kanekiyo, Nobuaki Suzuki, Shigeru Takeda, Tomio Ueno, Shigefumi Yoshino, Shoichi Hazama, Hiroaki Nagano.   

Abstract

Case 1: A 57-year-old woman with chronic hepatitis related to the hepatitis B virus was found to have a liver tumor on ultrasonography(US). Computed tomography(CT), magnetic resonance imaging(MRI), and angiography revealed 2 tumors in the liver. The patient underwent right anterior sectorectomy, and histopathologic analysis revealed mucosa-associated lymphoid tissue(MALT)lymphoma. Thirty months later, recurrence was confirmed using liver biopsy. CR was confirmed after radiation and chemotherapy, and the patient has survived. Case 2: A 71-year-old woman came to our hospital for rheumatism treatment. US, CT, and MRI revealed a tumor in the left lateral segment of the liver. The patient underwent laparoscopic partial liver resection and histopathologic analysis revealed MALT lymphoma. The patient has survived.

Entities:  

Mesh:

Year:  2016        PMID: 28133134

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  A case of primary hepatic extranodal marginal zone B-cell mucosa-associated lymphoid tissue (MALT) lymphoma treated by radiofrequency ablation (RFA), and a literature review.

Authors:  Zhe Xu; Chong Pang; Jidong Sui; Zhenming Gao
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

2.  Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection: Case Report and Summary of the Literature.

Authors:  Yuki Yamashita; Satoru Joshita; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Ayumi Sugiura; Tomoo Yamazaki; Takeji Umemura
Journal:  Medicina (Kaunas)       Date:  2021-03-18       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.